Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 19Unknown 14Recruiting 14Terminated 9Withdrawn 3Not yet recruiting 3Suspended 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Sarcoma 1Recurrent respiratory papillomatosis 1Papilloma 1Neoplasm Metastasis 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Propranolol × Clear all
NCT06670976 2025-08-26

Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

Roswell Park Cancer Institute

Phase 1 Withdrawn
Sarcoma

Sarcoma

NCT03323710 2019-01-09

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Military Institute od Medicine National Research Institute

Phase 2 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT01058317 2013-11-21

Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis

Massachusetts Eye and Ear Infirmary

Phase 2/3 Withdrawn

Recurrent respiratory papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡